TRNS
Transcat, Inc.
$86.23
-0.17
(-0.20%)
Mkt Cap
807.10M
Volume
85,563
52W Range
50.23-100
Sector
Industrials
Beta
0.66
EPS (TTM)
0.37 USD
P/E Ratio
233.05
Revenue (TTM)
348.40M USD
Rev Growth (5Y)
+11.5%
EPS Growth (5Y)
-10.1%
AlphaVal · Fair Value
What we estimate one share is worth
$26.05
Overvalued
strong signal
231.0% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
C-
Platform & Compounding FCF
50.4 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.
Company Description
Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 331.88M | 278.42M | 259.48M | 230.57M | 204.96M | 173.34M | 173.10M | 160.90M | 155.14M | 143.90M | 122.17M | 123.62M |
| Net Income | 5.38M | 14.52M | 13.65M | 10.69M | 11.38M | 7.79M | 8.07M | 7.14M | 5.92M | 4.52M | 4.12M | 4.03M |
| EPS | 0.58 | 1.58 | 1.66 | 1.42 | 1.52 | 1.05 | 1.10 | 0.99 | 0.83 | 0.65 | 0.60 | 0.59 |
| Free Cash Flow | 19.55M | 25.79M | 19.34M | 7.54M | 7.47M | 17.02M | 4.98M | 5.56M | 3.99M | 2.29M | 6.88M | 939,000 |
| FCF / Share | 2.09 | 2.81 | 2.35 | 1.00 | 1.00 | 2.29 | 0.68 | 0.77 | 0.56 | 0.33 | 1.00 | 0.14 |
| Operating CF | 34.85M | 38.98M | 32.62M | 16.95M | 17.62M | 23.64M | 11.56M | 12.56M | 9.87M | 7.54M | 10.98M | 4.44M |
| Total Assets | 480.49M | 385.24M | 287.55M | 195.75M | 177.76M | 132.12M | 128.12M | 105.23M | 96.82M | 92.10M | 76.71M | 62.15M |
| Total Debt | 128.88M | 57.73M | 21.54M | 64.41M | 57.65M | 27.52M | 37.18M | 21.00M | 22.85M | 27.31M | 19.07M | 12.17M |
| Cash & Equiv | 4.94M | 1.52M | 19.65M | 1.53M | 1.40M | 560,000 | 499,000 | 788,000 | 577,000 | 842,000 | 641,000 | 65,000 |
| Book Value | 300.62M | 286.88M | 225.17M | 99.63M | 86.18M | 75.08M | 67.09M | 59.63M | 51.35M | 43.40M | 38.91M | 34.32M |
| Return on Equity | 0.02 | 0.05 | 0.06 | 0.11 | 0.13 | 0.10 | 0.12 | 0.12 | 0.12 | 0.10 | 0.11 | 0.12 |
| Metric | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 92.94M | 89.33M | 83.86M | 82.27M | 77.13M | 77.13M | 67.83M | 67.83M | 66.71M | 70.91M | 65.17M | 62.80M |
| Net Income | 1.33M | 1.95M | (1.10M) | 1.27M | 4.46M | 4.46M | 3.29M | 3.29M | 4.41M | 6.89M | 3.35M | 460,000 |
| EPS | 0.14 | 0.21 | -0.12 | 0.14 | 0.48 | 0.49 | 0.36 | 0.36 | 0.49 | 0.82 | 0.39 | 0.06 |
| Free Cash Flow | 4.83M | 2.59M | 9.49M | 8.42M | (975,000) | 7.93M | 9.73M | 2.88M | 5.25M | 1.55M | 7.26M | 5.76M |
| FCF / Share | 0.52 | 0.28 | 1.03 | 0.90 | -0.11 | 0.86 | 1.06 | 0.31 | 0.58 | 0.18 | 0.84 | 0.74 |
| Operating CF | 8.82M | 6.17M | 12.17M | 12.86M | 3.62M | 10.63M | 12.60M | 6.83M | 8.92M | 5.73M | 10.92M | 8.44M |
| Total Assets | 492.63M | 480.49M | 472.89M | 484.89M | 392.54M | 385.24M | 386.01M | 323.55M | 323.65M | 287.55M | 281.07M | 248.21M |
| Total Debt | 143.25M | 128.88M | 134.00M | 147.75M | 65.72M | 57.73M | 66.02M | 17.66M | 22.16M | 21.54M | 22.06M | 67.83M |
| Cash & Equiv | 6.71M | 4.94M | 3.47M | 5.08M | 1.86M | 1.52M | 4.64M | 23.82M | 22.66M | 19.65M | 35.20M | 1.25M |
| Book Value | 302.90M | 300.62M | 296.77M | 295.42M | 292.54M | 286.88M | 281.08M | 268.76M | 262.29M | 225.17M | 218.47M | 138.25M |
| Return on Equity | 0.00 | 0.01 | -0.00 | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 | 0.00 |
TRNS News
Is Transcat Inc (TRNS) a Bargain After 3.0% Drop? GF Value Says Undervalued
Transcat Holdings: Recent Share Price Weakness Provides A Solid Entry Point
Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical
Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September
Dimensional Fund Advisors LP Grows Position in Transcat, Inc. $TRNS
Transcat, Inc. (TRNS) Q1 2027 Earnings Call Transcript
Transcat Q1 Earnings Call Highlights
Transcat, Inc. (TRNS) Q1 Earnings and Revenues Top Estimates
Transcat Reports Strong Fiscal First Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Service Gross Margin Expansion
Transcat to Host First Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, August 4, 2026 at 4:30 p.m. Eastern Time